A study to assess the effects of PT003 and Placebo MDI on specific image based airway volumes and resistance in subjects with moderate to severe COPD

Trial Identifier: PT003018
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT02643082
Start Date: December 2015
Primary Completion Date: January 2017
Study Completion Date: January 2017
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Belgium Edegem, Belgium, 2650